Use introduction/alteration of DNA sequences to create a therapeutic benefit
Gene therapies are not new, but CRISPR/Cas9 is making this much easier and more precise, which is opening up new possibilities
Gene therapies using viruses to introduce new DNA sequences to integrate randomly into the genome have been around for awhile and are still used routinely
Regenerative medicine
Seeks to restore tissue structure and function and provide options for what were previously untreatable injuries or diseases
Regenerative medicine approaches can involve cell therapy, gene therapy, and/or tissue bioengineering
Sickle cell disease
An inherited blood disorder caused by a single nucleotide change that alters a single amino acid in the gene for β-globin, a subunit in hemoglobin, causing abnormal clumped protein fibers
CRISPR gene therapy for sickle cell disease
Patient's hematopoietic stem cells are isolated and edited to correct the single nucleotide change, then re-introduced to the patient after chemotherapy to remove existing unedited hematopoietic stem cells
Induced pluripotent stem cells (iPSCs)
Discovered in 2012, these are master regulators of pluripotency
Cord blood is FDA approved as a source of hematopoietic stem cells to treat diseases of the blood/immune system (ex. leukemia and sickle cell anemia)
The only stem cell products that are FDA-approved for use in the United States consist of blood-forming stem cells
Autocrine, juxtracrine, and endocrine signaling pathways
Types of cell-to-cell communication
Cell surface vs nuclear receptors
Cell surface receptors mediate rapid signaling responses, nuclear receptors are transcription factors that regulate gene expression
ECM and integrin signaling can influence cell function and cell survival
Morphogens
Signaling molecules that influence cell fate in a concentration-dependent manner
Signaling mechanisms
1. Phosphorylation
2. GTP binding
Mutations in signaling pathways
Can produce oncogenes with uncontrolled signaling
Gene regulation occurs at the post-translational level
Molecular chaperones
Assist protein folding to the correct and most stable form
Molecular chaperones
Heat shock proteins (hsps)
Misfolded proteins are degraded by proteasomes
Proteasomes
Abundant sites for protein degradation, with protease activity isolated inside a hollow cylinder
Proteins can be marked for proteasomal degradation by addition of a polyubiquitin chain
Ubiquitin
A small protein that can be covalently added to different sites on proteins by ubiquitin ligases to regulate their function
Regulation of protein degradation
1. Signals activate ubiquitin ligase complexes
2. Ubiquitinated proteins are sent to the proteasome for degradation
Post-translational modifications allow rapid changes in protein activity, localization, and stability
Signalingpathways are interconnected and can branch out to impact many cell functions
Endocrine, paracrine, and juxtacrine signaling
Types of intercellular communication
Nuclear receptors
Transcription factors that translocate to the nucleus upon ligand binding
Receptors expressed and signals received determine cell function
Integrins
Transmembrane proteins that help cells adhere to the extracellular matrix and transmit signals
Anoikis is apoptosis due to loss of integrin-mediated cell adhesion
Mammary epithelial cells
Extracellular matrix signals direct normal structure and function
Signaling responses can be "fast" (protein modification) or "slow" (gene expression)
Positive and negative feedback in signaling pathways
Shapes the duration and dynamics of signaling
GTPases
Molecularswitches in signaling pathways, with GTP-bound form being active
Kinases and phosphatases
Enzymes that add and removephosphate groups, creating molecular switches
Mutations affecting GTPase or kinase signaling are common in cancer and can create oncogenes